ZTX
"ZTX" is a word mark owned by Bioreperia AB, filed at the USPTO on June 15, 2020. It is registered and covers classes 10, 35, 42 and 44.
- Status
- Registered
- Since September 13, 2022
- Filed
- June 15, 2020
- Registered
- September 13, 2022
- Expires
- Not recorded
- Application no.
- 79299712
- Registration no.
- 6841276
- Office
- USPTO
- United States Patent and Trademark Office
- Mark type
- Word mark
- 4 classes
Who owns ZTX
The owner on file, matched to the company behind it. Every owner-name spelling for that company is grouped on its page.
Owner
Bioreperia AB
Sweden
Representative
Arlene D Hanks
Moore & van Allen PLLC
What the mark covers
The products and services ZTX is filed for, grouped by Nice class.
Diagnostic, examination, and monitoring equipment, namely, medical diagnostic apparatus for testing cancer tissues incorporating recorded operating system software; medical imaging apparatus; image management systems for medical purposes, namely, medical imaging apparatus with embedded operating system and analytical software
Database management for others, namely, input, processing, checking, storage and retrieval of computer data; data processing services in the nature of processing and control of computerized information; data, database, file and records management in relation to business management and administration; retail store services featuring image apparatus, computers, computer programs, pharmaceutical preparations, pharmaceutical goods and goods for medical diagnostics; compiling indexes of information for others relating to information, homepages and other resources available via global computer networks and other electronic communications networks; compilation of statistical data relating to medical research for business purposes
Scientific and technological services, namely, research and product design in the fields of medicine and pharmacology; industrial analysis services, namely, laboratory analysis services in the medical and pharmaceutical fields; industrial research in the field of medicine and pharmacology; providing medical and scientific research information in the field of pharmaceuticals and clinical trials; drug discovery services; providing information and data relating to pharmaceutical and medical research and development; software design and development; software as a service (SaaS) services featuring software for recording, transmission, reproduction, storage and processing of files, test results, documents, texts, videos and images in the pharmaceutical and medical fields; platform as a service (PaaS) featuring computer software platforms for processing of pharmaceutical and medical files, test results, documents, texts, sound and images; computer services, namely, cloud hosting provider services; programming of computer software for pharmaceutical and medical application for others; electronic data storage; electronic storage of electronic media, namely files, data, documents, text, videos and images; computer services, namely, electronic digitizing of photographic images for medical purposes
Medical services; analysis and examination of medical images for purposes of medical diagnosis and providing medical advice relating to pharmacology; online analysis and examination of medical images for purposes of medical diagnosis and providing medical advice relating to pharmacology; medical laboratory analysis services relating to the medical treatment of persons; medical analysis services for diagnostic and treatment purposes provided by medical laboratories; consultancy services relating to health care; conducting of medical studies for medical diagnostic or treatment purposes in the field of oncology; medical services provided by analysis and examination of medical files, data, documents, text, videos, sound and images; medical services provided online by analysis and examination of medical files, data, documents, text, videos, sound and images; providing medical information
What has happened so far
Steps recorded by the USPTO, newest first.
- Final decision transaction processed by ib
- Final disposition notice sent to ib
- Final disposition processed
- Final disposition notice created, to be sent to ib
- Notice of registration confirmation emailed
- Registered-principal register
- Ttab release case to trademarks
- Opposition terminated no. 999999
- Opposition dismissed no. 999999
- Notification of possible opposition - processed by ib
10 earlier steps on the official record.
Oppositions and cancellations
Proceedings recorded against this mark by the USPTO. Reported as recorded, not legal advice.
About ZTX
Who owns the trademark "ZTX"?
The USPTO trademark "ZTX" (application 79299712) is owned by Bioreperia AB.
What is the status of "ZTX"?
Its status at the USPTO is: registered.
When was "ZTX" registered?
It was registered on September 13, 2022.
Get this data via the API
Everything on this page comes from the Signa API. Pull ZTX and marks like it into your own product with one request.
GET/v1/trademarks/{id}The full record: owners, classes, dates and images
GET/v1/trademarks/{id}/eventsEvery step in the office history
GET/v1/proceedings?trademark_id={id}Oppositions and cancellations against the mark
ID=tm_019d2afd-17d6-7165-ad00-e3f67dee66f3
curl https://api.signa.so/v1/trademarks/$ID \
-H "Authorization: Bearer $SIGNA_API_KEY"{
"id": "tm_019d2afd-17d6-7165-ad00-e3f67dee66f3",
"object": "trademark",
"mark_text": "ZTX",
"status": {
"primary": "active",
"stage": "registered"
},
"office_code": "US",
"application_number": "79299712",
"filing_date": "2020-06-15",
"nice_classes": [
10,
35,
42,
44
],
"owners": [
{
"name": "Bioreperia AB",
"entity_id": "ent_019ebb5a-ea17-736b-b701-a81770d18dc5"
}
]
}